Lexaria Bioscience Corp. (LEXX)
Nasdaq: LEXX · Pharmaceutical Preparations · Kelowna, BC · filing with the SEC since 2006
Who runs Lexaria Bioscience Corp.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Bunka Christopher
Chief Executive Officer. First filing Nov 2006, latest Mar 18, 2026, 23 filings in all.
Officers reporting now
4
of 5 people with a filing in the last fifteen months
Directors reporting now
1
14 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bunka Christopher | Chief Executive Officer | Nov 2006 | Mar 18, 2026 | none |
| Christopher Richard | Chief Executive Officer | Sep 2024 | Jul 30, 2025 | none |
| Docherty John Martin | President & CSO | Apr 2015 | Jul 30, 2025 | none |
| Carle Vanessa | Secretary | Apr 2021 | Jul 30, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mckechnie William Edward | director | Nov 2015 | Jul 30, 2025 | none |
Earlier names on the record9, newest filing first
Bhullar Baljinder · officer · last filing May 2025Shankman Michael Elliot · officer · last filing May 2025Baxter Nicholas W · director · last filing May 2025Reese Albert L Jr · director · last filing May 2025Turkel Catherine C. · director · last filing Aug 2024Cabatuan Nelson · officer · last filing Mar 2024Downey Gregory · officer · last filing Oct 2022Spissinger Allan Horst · officer · last filing Apr 2020Quigley Brian W. · director · last filing Apr 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.